Related Experiment Video
Updated: May 5, 2026
An Ex Vivo Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth
Published on: September 22, 2021
In Vitro Cytotoxic Effects of Dibromodulcitol in 9L Rat Brain Tumor Cells
S M Pulst1, V A Levin, D F Deen
1Brain Tumor Research Center of the Department of Neurological Surgery, School of Medicine, University of California, San Francisco, California, 94143.
Abstract:
Dibromodulcitol (DBD) is a halogenated hexitol active against animal and human brain tumors in vivo. In aqueous solution, DBD is transformed to products with different cytotoxicities. We studied the in vitro activation and inactivation of DBD with a bioassay in 9L rat brain tumor cells. We developed a mathematical model to calculate the rate constants of activation and inactivation. The kinetics of the activation and inactivation of DBD transformation products in cell culture medium were exponential, with rate constants of 0.139 and 0.0189 hr(-1), respectively. The maximum cell kill was caused by DBD that had been preincubated in medium for 13-16 hr. Thus cell kill is not caused by parent drug but by active transformation products.
More Related Videos
12:28Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023